Literature DB >> 21131904

TDP-43 regulates its mRNA levels through a negative feedback loop.

Youhna M Ayala1, Laura De Conti, S Eréndira Avendaño-Vázquez, Ashish Dhir, Maurizio Romano, Andrea D'Ambrogio, James Tollervey, Jernej Ule, Marco Baralle, Emanuele Buratti, Francisco E Baralle.   

Abstract

TAR DNA-binding protein (TDP-43) is an evolutionarily conserved heterogeneous nuclear ribonucleoprotein (hnRNP) involved in RNA processing, whose abnormal cellular distribution and post-translational modification are key markers of certain neurodegenerative diseases, such as amyotrophic lateral sclerosis and frontotemporal lobar degeneration. We generated human cell lines expressing tagged forms of wild-type and mutant TDP-43 and observed that TDP-43 controls its own expression through a negative feedback loop. The RNA-binding properties of TDP-43 are essential for the autoregulatory activity through binding to 3' UTR sequences in its own mRNA. Our analysis indicated that the C-terminal region of TDP-43, which mediates TDP-43-hnRNP interactions, is also required for self-regulation. TDP-43 binding to its 3' UTR does not significantly change the pre-mRNA splicing pattern but promotes RNA instability. Moreover, blocking exosome-mediated degradation partially recovers TDP-43 levels. Our findings demonstrate that cellular TDP-43 levels are under tight control and it is likely that disease-associated TDP-43 aggregates disrupt TDP-43 self-regulation, thus contributing to pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21131904      PMCID: PMC3025456          DOI: 10.1038/emboj.2010.310

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  46 in total

1.  SC35 autoregulates its expression by promoting splicing events that destabilize its mRNAs.

Authors:  A Sureau; R Gattoni; Y Dooghe; J Stévenin; J Soret
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

2.  TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations.

Authors:  Manuela Neumann; Ian R Mackenzie; Nigel J Cairns; Philip J Boyer; William R Markesbery; Charles D Smith; J Paul Taylor; Hans A Kretzschmar; Virginia E Kimonis; Mark S Forman
Journal:  J Neuropathol Exp Neurol       Date:  2007-02       Impact factor: 3.685

3.  Mammalian Staufen1 recruits Upf1 to specific mRNA 3'UTRs so as to elicit mRNA decay.

Authors:  Yoon Ki Kim; Luc Furic; Luc Desgroseillers; Lynne E Maquat
Journal:  Cell       Date:  2005-01-28       Impact factor: 41.582

4.  TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Tetsuaki Arai; Masato Hasegawa; Haruhiko Akiyama; Kenji Ikeda; Takashi Nonaka; Hiroshi Mori; David Mann; Kuniaki Tsuchiya; Mari Yoshida; Yoshio Hashizume; Tatsuro Oda
Journal:  Biochem Biophys Res Commun       Date:  2006-10-30       Impact factor: 3.575

5.  A Drosophila model for TDP-43 proteinopathy.

Authors:  Yan Li; Payal Ray; Elizabeth J Rao; Chen Shi; Weirui Guo; Xiaoping Chen; Elvin A Woodruff; Kazuo Fushimi; Jane Y Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-26       Impact factor: 11.205

6.  Regulation of multiple core spliceosomal proteins by alternative splicing-coupled nonsense-mediated mRNA decay.

Authors:  Arneet L Saltzman; Yoon Ki Kim; Qun Pan; Matthew M Fagnani; Lynne E Maquat; Benjamin J Blencowe
Journal:  Mol Cell Biol       Date:  2008-04-28       Impact factor: 4.272

7.  A protein interaction framework for human mRNA degradation.

Authors:  Ben Lehner; Christopher M Sanderson
Journal:  Genome Res       Date:  2004-07       Impact factor: 9.043

8.  Depletion of TDP-43 affects Drosophila motoneurons terminal synapsis and locomotive behavior.

Authors:  Fabian Feiguin; Vinay K Godena; Giulia Romano; Andrea D'Ambrogio; Raffaella Klima; Francisco E Baralle
Journal:  FEBS Lett       Date:  2009-04-19       Impact factor: 4.124

9.  Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping.

Authors:  E Buratti; T Dörk; E Zuccato; F Pagani; M Romano; F E Baralle
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

10.  An integrated workflow for charting the human interaction proteome: insights into the PP2A system.

Authors:  Timo Glatter; Alexander Wepf; Ruedi Aebersold; Matthias Gstaiger
Journal:  Mol Syst Biol       Date:  2009-01-20       Impact factor: 11.429

View more
  263 in total

Review 1.  TDP-43 aggregation in neurodegeneration: are stress granules the key?

Authors:  Colleen M Dewey; Basar Cenik; Chantelle F Sephton; Brett A Johnson; Joachim Herz; Gang Yu
Journal:  Brain Res       Date:  2012-02-22       Impact factor: 3.252

Review 2.  Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration.

Authors:  Edward B Lee; Virginia M-Y Lee; John Q Trojanowski
Journal:  Nat Rev Neurosci       Date:  2011-11-30       Impact factor: 34.870

3.  Algorithm to identify frequent coupled modules from two-layered network series: application to study transcription and splicing coupling.

Authors:  Wenyuan Li; Chao Dai; Chun-Chi Liu; Xianghong Jasmine Zhou
Journal:  J Comput Biol       Date:  2012-06       Impact factor: 1.479

4.  The ALS disease protein TDP-43 is actively transported in motor neuron axons and regulates axon outgrowth.

Authors:  Claudia Fallini; Gary J Bassell; Wilfried Rossoll
Journal:  Hum Mol Genet       Date:  2012-05-28       Impact factor: 6.150

Review 5.  Neuropathology of Amyotrophic Lateral Sclerosis and Its Variants.

Authors:  Shahram Saberi; Jennifer E Stauffer; Derek J Schulte; John Ravits
Journal:  Neurol Clin       Date:  2015-11       Impact factor: 3.806

6.  TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD.

Authors:  Jonathan P Ling; Olga Pletnikova; Juan C Troncoso; Philip C Wong
Journal:  Science       Date:  2015-08-07       Impact factor: 47.728

Review 7.  TDP43 and RNA instability in amyotrophic lateral sclerosis.

Authors:  Kaitlin Weskamp; Sami J Barmada
Journal:  Brain Res       Date:  2018-01-31       Impact factor: 3.252

8.  Point mutations in the N-terminal domain of transactive response DNA-binding protein 43 kDa (TDP-43) compromise its stability, dimerization, and functions.

Authors:  Miguel Mompeán; Valentina Romano; David Pantoja-Uceda; Cristiana Stuani; Francisco E Baralle; Emanuele Buratti; Douglas V Laurents
Journal:  J Biol Chem       Date:  2017-05-31       Impact factor: 5.157

Review 9.  Faulty RNA splicing: consequences and therapeutic opportunities in brain and muscle disorders.

Authors:  Vittoria Pagliarini; Piergiorgio La Rosa; Claudio Sette
Journal:  Hum Genet       Date:  2017-04-22       Impact factor: 4.132

Review 10.  TDP-43/FUS in motor neuron disease: Complexity and challenges.

Authors:  Erika N Guerrero; Haibo Wang; Joy Mitra; Pavana M Hegde; Sara E Stowell; Nicole F Liachko; Brian C Kraemer; Ralph M Garruto; K S Rao; Muralidhar L Hegde
Journal:  Prog Neurobiol       Date:  2016-09-28       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.